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Background:  
 
Controversies persist regarding the effect of different transfusion ratios of fresh frozen 
plasma(FFP): packed red blood cell(RBC) on mortality. Observational evidence suggests a survival 
benefit for a high ratio in trauma patients, however, a recent, large, randomized controlled trial 
did not confirm this benefit. In recent years, the effect of this ratio has also been investigated in 
non-trauma settings. We herein offer an updated meta-analysis with the most recent literature 
and for the first time include a non-trauma cohort.  
 
Methods:  
 
A systematic review of balanced transfusion in trauma/on-trauma populations was conducted. 
Patients were categorized into high vs. low FFP:RBC ratio. Primary outcomes were 24-hour and 
30-day/in-hospital mortality. Secondary outcomes were mortality differences in trauma vs non-
trauma patients, mortality differences based on different transfusion ratio cutoffs (1:1, 1:1.5, or 
1:2) and differences in acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) 
rates based on these ratios. Random model and leave-one-out-analyses were used.  
 
Results:  
 
36 studies with 16,607 patients were included; 34 traumas(16,027cases) and 2 non-trauma(580 
cases; cardiac and vascular). 
When pooling all studies together lower ratio was associated with poorer survival at 24-
hr(OR=2.41;CI=1.94-3.01,p<0.001) and at 30-days (OR:1.74,CI=1.51-2.02,p<0.001). 
In trauma settings, a lower ratio was associated with worse 24-hour and 30-day 
mortality(OR:2.41,CI=1.94-3.01,p<0.001 and OR:1.71,CI=1.47-1.98,p<0.001 respectively).  
In non-trauma patients a lower ratio was associated with worse 30-day mortality(OR:2.60,CI 
=1.51-4.49,p<0.001).  
In the entire cohort, a ratio of 1:1.5 provided the largest survival benefit at 24-hours and 30-
days(OR:3.97,CI=1.37-11.49,p<0.001) and(OR:2.31,CI=1.17-4.57,p<0.001). There was no 
association between the ratio and ARDS or ALI.  
Conclusions:  
 
High FFP:RBC ratio confers both 24-hour and 30-day/in-hospital survival benefits, which were 
noted in trauma and non-trauma settings. A ratio of 1:1.5 was associated with the highest survival 
benefit.  
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Controversies persist regarding the effect of different transfusion ratios of fresh frozen plasma 
(FFP): packed red blood cell (RBC) on mortality. Observational evidence suggests a survival 
benefit for a high ratio in trauma patients, however, a recent, large, randomized controlled trial 
did not confirm this benefit. In recent years, the effect of this ratio has also been investigated in 
non-trauma settings. We herein offer an updated meta-analysis with the most recent literature 
and for the first time include a non-trauma cohort.  
 
Methods:  
 
A systematic review of the literature on balanced transfusion in both trauma and non-trauma 
populations was conducted. Patients were categorized into groups of high vs. low based on FFP: 
RBC ratio. Primary outcomes were 24-hour and 30-day/in-hospital mortality. Secondary 
outcomes were mortality differences in trauma vs non-trauma patients, mortality differences 
based on different transfusion ratio cutoffs (1:1, 1:1.5, or 1:2) and differences in acute respiratory 
distress syndrome (ARDS) and acute lung injury (ALI) rates based on these ratios. Random model 
and leave-one-out-analyses were used.  
 
Results:  
 
36 studies (2 RCTs, 34 observational) reporting outcomes on 16,607 patients were included; 34 
traumas (16,027cases) and 2 non-trauma (580 cases; cardiac and vascular). 
When pooling all studies together lower ratio was associated with poorer survival at 24-hr 
(OR=2.41; CI=1.94-3.01, p<0.001) and at 30-days (OR:1.74, CI=1.51-2.02, p<0.001). 
In trauma settings, a lower ratio was associated with worse 24-hour and 30-day mortality 
(OR:2.41, CI=1.94-3.01, P<0.001 and OR:1.71, CI=1.47-1.98, P<0.001 respectively).  
In non-trauma patients a lower ratio was associated with worse 30-day mortality (OR:2.60, CI 
=1.51-4.49, p<0.001).  
In the entire cohort, a ratio of 1:1.5 provided the largest survival benefit at 24-hours and 30-days 
(OR:3.97,CI=1.37-11.49,p<0.001) and (OR:2.31,CI=1.17-4.57,p<0.001). There was no association 
between the ratio and ARDS or ALI.  
Conclusions:  
 
High FFP: RBC ratio confers both 24-hour and 30-day/in-hospital survival benefits, which were 
noted in trauma and non-trauma settings. A ratio of 1:1.5 was associated with the highest survival 
benefit.  
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Introduction 
 
 The use of 1:1 balanced transfusion in massive traumatic hemorrhage has been an 
important topic over the past decade1–4. Until recently the primary method of resuscitation in 
massive hemorrhage was utilizing crystalloid and packed red blood cells (RBCs) and correcting 
coagulopathy as it arose. During the wars in Iraq and Afghanistan, the U.S. military utilize whole 
blood in austere situations for massive blood transfusion due to a rapidly available pool of 
donors. Initial studies on this transfusion method suggested that whole blood was as good as, 
and perhaps even superior to, traditional component transfusion practices with regards to 
coagulopathy in the setting of massive hemorrhage 5–7. Other studies from civilian trauma 
suggested an advantage with early transfusion of FFP and platelets 8–10. In a 2007 landmark 
retrospective study Borgman and colleagues 11 demonstrated that by attempting to recreate 
whole blood by balanced transfusion  of individual blood products, mortality could be improved 
in a cohort of hemorrhaging patients in a combat setting. This and other small studies led to a 
directive within the U.S. military for a balanced, 1:1 ratio of blood products in massive transfusion 
when feasible.  
Over the next several years, balanced transfusion  was applied and studied throughout civilian 
trauma systems in numerous retrospective studies, yielding generally improved mortality when 
compared to unbalanced transfusion ratios. The practice remained controversial as the studies 
were retrospective and it was argued that many were subject to a survival bias since less severely 
injured patients were more likely to receive or achieve balanced transfusion12. This led to one 
prospective observational cohort study and one major randomized control trial (RCTs); The 
Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) 13 study, and 
The Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality 
in Patients with Severe Trauma (PROPPRR) Trial 14. The PROMMTT trial included patients who 
received a much lower number of blood products but still demonstrated increased survival with 
balanced transfusion  early in the hospital course. Interestingly, the PROPPR trial did not 
demonstrate improved overall 24-hour or 30-day mortality but did demonstrate decreased 
mortality at 24 hours from exsanguination.  There is very limited information regarding the 
effectiveness of balanced transfusion in other surgical specialties, likely because the transfusion 
practices for other surgical subspecialties are not standardized. The goal of this systematic 
analysis is to compare the effect of balanced, massive transfusion on mortality and secondary 
outcomes including acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) in a 
large, cohort of surgical patients, including both trauma and non-trauma sub specialties.  
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Methods 
 
Study selection 
 
A literature review using PubMed, MEDLINE, EMBASE, Web of Science, Science Direct, and 
Google scholar databases was performed by two independent investigators (MR and MK) up to 
January 10th, 2016. The following search terms were used:  
(trauma OR traumatic OR injur* OR wound*) AND (massive OR major) AND (haemorrhag* OR 
hemorrhag* OR bleed* OR transfus* OR blood) AND (plasma OR component) AND (mortal* OR 
death* OR die OR died). Another search conducted by replacement of (trauma OR traumatic OR 
injur* OR wound*) by surgery in order to recruit non-trauma articles. In addition, upon 
identifying other meta-analyses or systematic reviews, references were scanned to capture 
relevant articles and pertinent reviews (i.e., backward snowballing). In case of disagreement a 
third investigator (MG) was included and an agreement was negotiated. 
 
Study inclusion criteria 
 
Studies included met the following criteria: (I) design was RCT or observational studies written in 
English, with more than 20 participants in each arm of the comparison; (II) massive blood 
transfused patients (all definitions accepted); (III) available mortality data based on the 
transfused FFP: RBC ratio; (IV) comparisons were made to contemporaneous patient cohorts, not 
to historical controls; (V) when cohorts overlapped between two studies, the more recent study 
was included.  
 
Data extraction 
 
Microsoft Office Excel 2010 (Microsoft, Redmond, Washington) was used for data extraction. 
Data extraction of all included studies was performed independently by 2 investigators (MR, DJ) 
and in case of disagreement a third investigator (MG) was included and an agreement was 
negotiated.  
Extracted variables were: study name, publication year, study design, number of patients, sex, 
mean age, mean injury severity score (ISS), blunt injury percentage, military versus civilian 
environment, definition of massive transfusion, different FFP: RBC ratio categories, cut-off with 
different events number and total patients number in each group (then, categories were grouped 
as being low vs high for each study according to a predetermined ratios (1:1, 1:1.5, or 1:2) for 
analysis purposes), 24-hour mortality, 30-day/in-hospital mortality (if both were available, only 
in-hospital mortality data were used), morbidity outcomes (including ARDS and ALI), non-
significant and significant differences between the different FFP: RBC ratio groups, factors 
associated with survival in the studied cohorts and lengths of hospital stay (LOS). The Newcastle-
Ottawa Scale (NOS) was used to assess the quality of included studies 15. Only high quality studies, 
defined as those achieving seven or more stars, were included in this review. 
 
Study outcomes 
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Primary outcomes were 24-hr mortality and 30-day/in-hospital mortality for high vs low FFP: RBC 
ratio in the whole cohort while secondary outcomes were (I) mortality differences in trauma vs. 
non-trauma patients regarding FFP: RBC ratio, (II) mortality differences around the different cut-
off ratios (1:1, 1:1.5, or 1:2) in order to identify the most beneficial ratio, and (III) ALI and ARDS 
differences between high vs. low ratios. 
 
 
Statistical analysis 
 
Review Manager Version 5.3  (RevMan) 16 was used to perform this pairwise meta-analysis, which 
was performed according to guidelines from the Meta-analysis of Observational Studies in 
Epidemiology (MOOSE) group 17 and from the Preferred Reporting Items for Systematic reviews 
and Meta-Analysis group (PRISMA) 18. The average of reported means of different studies was 
gathered for continuous variables. 
 
The estimated survival data were obtained from the relevant articles either directly from 
published tables or indirectly from Kaplan–Meier curves using a previously described method 19 
with aid of GetData Graph Digitizer software (http://getdata-graph-digitizer.com/).  
 
Individual and pooled odds ratio (OR) with 95% confidence intervals (CI) were calculated by 
means of the DerSimonian-Laird (inverse variance [IV]) method 20. OR was our measure for mortality 
as a dichotomous outcome with OR >1 indicating greater risk of an adverse event (i.e. death or 
complication as ARDS or ALI) happening in the low ratio group. P value <0.05 was used to indicate 
statistical significance.  
 
Statistical heterogeneity was tested by the Cochran Q-test, with statistical significance set at the 
two-tailed 0.10 level, while extent of statistical consistency was measured with I2 that equals to 
100% X (Q-df)/Q; where Q is Cochran’s heterogeneity statistic and df is the degrees of freedom. 
 
The fixed-effect model was used in case of low statistical inconsistency (I2 ≤25%) while random-
effect model, that better accommodates clinical and statistical variations, in case of moderate or 
high statistical inconsistency (I2 >25%). Higher values of I2 signified increasing levels of 
heterogeneity between included studies with p-value <0.05 was considered evidence for 
significant heterogeneity. Publication bias was assessed by funnel plots. Subgroup analysis was 
performed based on whether studies were conducted in trauma versus non-trauma settings. 
Sensitivity analysis using leave-one-out analysis was performed by Comprehensive Meta-Analysis 
software, version 2 (Biostat, Englewood, NJ, USA).  
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Results 
 
Included studies 
 
Initially, 1,321 articles were identified through the PubMed search, with an additional 48 articles 
added through backward snowballing. Following review of titles and abstract, only 93 full text 
articles were assessed for final eligibility, among them only 36 studies (2 RCTs and 34 
observational studies)1–4,11,12,14,21–49 were included on the basis of our pre-defined 
inclusion/exclusion criteria (Figure 1).  All but two retrospective studies 32,33, were from trauma 
settings.  
 
Demographics of included studies  
 
Total number of patients among the 34 trauma studies was 16,607 and of the 2 non-trauma (i.e. 
cardiac and vascular) articles was 580 patients. Twenty-eight studies were from civilian hospitals, 
4 from military settings, and 4 from combined civilian/military settings. The majority of the 
included studies (31 studies) defined massive transfusion as 10 units of RBCs/24 hrs. Twenty-six 
articles were from the United States, 7 from Europe, 2 from Asia and 1 from Canada (Table 1). 
 
The mean age was 39.1 years (range 23.5-73 years) for the entire cohort, while for trauma-only 
cases, the mean age was 37.1 years (range 23.5-47 years) versus 66.7 years (range 60.3-73 years) 
for non-trauma cases. Overall, 63% of trauma was blunt (range 3-100%), 23% of the population 
was female (range 2-39%), the average ISS was 31.99 (range 14.6-42.5), and the average baseline 
hemoglobin and platelets values were 10.60 g/dl and 189,100 μL respectively. 
 
A total of 18/36 (50%) studies reported a FFP: RBC ratio ratio of 1:2 while 9 studies reported a 
ratio of 1:1 (Table 2). A ratio of 1:1.5 was reported in 6 articles and additional 3 studies reported 
their outcomes regarding various ratios (2:3 in 2 studies; and 1:2.3 in 1 study) (Figure 1). 
 
Mortality 
 
Short-term 
24-hr morality was described by 22 studies, revealing higher mortality for lower ratios (OR 2.41, 
CI 1.94-3.01 p<0.001, Figure 2A & B) (9, 15–35), although at varying ratio cut-offs. Ratios of 1:2 
were the most commonly reported, with 9 studies showing a deleterious effect with low ratio 
(OR: 2.85, CI 2.14-3.81). Seven articles reported  a ratio of 1:1 (OR: 2.05, CI 1.55-2.71), and only 
4 articles described a ratio of  1:1.5  (OR: 3.97, CI 1.37-11.49) (Table 3). 
 
Intermediate-term 
30-day/in-hospital mortality data were available from 27 studies (with different ratio cut-offs) 
and demonstrated higher mortality for lower ratios (OR: 1.74, CI 1.51-2.02, p<0.001, Figure 2C 
& D) (7, 9, 15, 18, 20–22, 25–29, 31–33, 36–47). 
Ratios of 1:2 were the most commonly reported, with 14 studies showing a deleterious effect of 
ratio less than 1:2 versus higher ratio (OR: 1.77, CI 1.50-2.10, p<0.001). Seven articles reported a 
ratio of 1:1 (OR: 1.36, CI 1.09-1.69), while only five articles showed 1:1.5  ratios (OR: 2.31, CI 1.14-
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5.25) which resulted in the highest OR among the various ratios. Figure 3 shows 24-hour and 30-
day/in-hospital mortality at different ratios. Funnel plots were created to assess for publication 
bias. (Supplementary figure1) 
 
Lower FFP: RBC ratio was associated with an increase in mortality rate among both trauma and 
non-trauma groups; however, this was more pronounced among non-trauma patients (OR: 2.60, 
CI 1.51-4.49 vs OR: 1.71, CI 1.47-1.98 for trauma cases), (Table 3, Supplementary figure 2) 
 
Heterogeneity was evident among nearly all of outcomes, except for 30-day/in-hospital mortality 
for non-trauma studies (I2=0%, P=0.32) and for ALI (I2=0%, P=0.73; Table 3); thus, a random model 
was commonly adopted in this study. 
Sensitivity studies using leave one out analysis of 24-hour and 30-day/in-hospital mortality at 
different ratios were done. (Supplementary figure 3) 
 
Morbidity 
 
ARDS data was available from 8 studies 2,14,28,29,35,40,45,46 and ALI data was reported in 2 studies 14,28. 
There was no difference in the incidence of ARDS with respect to FFP: RBC ratio (OR: 0.68, CI 
0.40-1.16, P=0.16). Similarly, no differences were observed in the incidence of ALI (OR: 1.23, CI 
0.81-1.86, P=0.34). (Supplementary figure 4) 
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Discussion 
 
The ideal ratio for balanced transfusion  is a controversial issue with multiple facts and 
considerations ranging from patient outcomes to allocation of resources 1,50. In their study 
Borgman and co-authors 11 found a higher transfusion ratio of 1:1.4 was significantly associated 
with improved mortality when compared to a medium (1:2.5) or low (1:8) ratios (19% vs 34% vs 
65%, p<0.001, respectively). Recently, the Eastern Association for the Surgery of Trauma (EAST)51 
recommended damage control resuscitation (DCR) that entails transfusion of equal amounts of 
RBC, FFP, and PLT during the early, empiric phase of resuscitation as it can significantly improve 
the outcomes in severely injured bleeding patients.  Civilian trauma centers around the world 
worked to create systems that could effectively transfuse quicker and at higher, more balanced 
ratios. The data that followed these changes was observational in nature. In general, the data 
from 2007 to 2015 supported balanced transfusion with a resultant improvement in the 24-hour 
and 30-day mortality rates. However, all of these studies were observational, which led to pleas 
for caution among many physicians. The main concern was that a paradigm shift was happening 
without high-quality evidence 52. Many of these studies are limited by survival bias since the exact 
timing of blood products transfusion was often unknown. In addition, it is likely that ratios have 
had changed over time, introducing a length time bias. That is to say, the patients who have had 
survived were probably  less injured, and thus, lived long enough to receive a balanced 
transfusion. Two smaller observational studies by Snyder et al. and Sperry et al. attempted to 
control for such survival bias, and are included in our analysis 12,40. These authors examined blood 
product ratios as time varying covariates and were unable to demonstrate a survival benefit 12,40.  
Noteworthy,  many centers did not have an effective balanced transfusion  protocol in place at 
the time of data collection. However, improving transfusion protocols (providing FFP in a timely 
manner) in many of these centers has resulted in a notable decline in mortality rates.  These 
findings support  the argument that by simply changing the transfusion protocol with a more 
readily available FFP, outcomes could improve as opposed to changing transfusion ratios.  
Riskin et al53 reported on the mortality rates of trauma patients 2 years before and 2 years after 
the implementation of a rapid  massive transfusion protocol (MTP) at a level 1 trauma center. 
One of the main goals was to enhance communication with the blood bank to decrease time to 
first transfusion. Other implemented changes included having a designated MTP leadership and 
supporting a transfusion ratio of 1:1.5. They were able to demonstrate their hypothesis by 
implementing these changes, and without altering ratios, the mortality rate in massively bleeding 
patients dropped from 45% to 19%. 
The first multicenter prospective observational cohort study, PROMMTT13 in 2013 sought to 
describe the timing of blood products provision and assess the association between in-hospital 
mortality and the timing and amount of blood products given. This paper was not limited to 
massive transfusion as it was a feasibility study for a future, larger RCT. The authors found that 
the majority of patients did not reach a balanced transfusion ratio until about 3-6 hours into 
admission. One of the most important findings of this study was that early balanced transfusion 
led to a decreased 24-hour mortality; a finding seen previously by Borgman in 2007, and thus, a 
change in availability of non-balanced blood was not the only factor involved.  
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In 2015, Holcomb and colleagues published their widely anticipated data from the PROPPR RCT 
which examined 680 trauma patients who received early balanced massive transfusion. The goal 
of this study was to address the primary concerns raised in previous studies. All patients who met 
rather broad inclusion criteria received blood products within a preset time. The authors found 
that the effects of a 1:1:1 vs 1:1:2 (FFP:PLT:RBC) transfusion ratio had no difference in overall 
mortality at 24 hours (12.7% vs 17.0%, p=0.12) or at 30 days (22.4% vs 26.1%, p=0.26). The 
authors also pointed out that like many trauma trials, about one third of the deaths reported in 
the study were from traumatic brain injury, and thus, may have contributed to the  failure to 
detect a significant difference in overall death rates 13. Our results show that a higher transfusion 
ratio, no matter the definition, leads to improved survival in 24-hour and 30-day/in-hospital 
mortality. This is in line with the rational for an early 1:1:1 transfusion regimen which seeks to 
provide rapid hemorrhage control by replacing blood loss with products to recreate the actual 
composition of blood. In our study, the data supported the largest benefit for survival at 24 hours 
vs. 30 days (OR: 2.41, CI 1.94-3.01 vs. OR: 1.76, CI 1.51-2.05). It seems self-evident that the role 
of early balanced transfusion  is most critical within the first hours of admission. As noted in 
PROMMTT and PROPPR study, after 24 hours is the time when other factors start to affect 
survival. 
Unlike the present analysis, prior meta-analyses54,55 did not include RCTs; in 2013 Bhangu et al54 
included six observational studies reporting the outcomes for 1,885 patients and reported a 
survival benefit with high FFP: RBC ratio without identifying additional benefits of 1:1 over 1:2 
ratios. In 2011 Rajasekhar et al55 published their meta-analysis of 11 observational studies that 
included 3,107 patients and found that there was an insufficient amount of evidence to support 
the survival advantage of a 1:1 ratio transfusion strategy. Our study is a large meta-analysis when 
compared with previous studies; including 36 articles, of which 2 are RTCs. The goal of this study 
was to look at mortality with relation to balanced transfusion among a broader range of surgical 
specialties. Of note, the goal of this paper was not to attempt to control for the inherent bias 
present in the observational studies. Instead, we wished to be as comprehensive as possible in 
regards to our inclusions. It is important that the readers understand that the primary source of 
our data is an observational trauma population. Articles about trauma represent  the best 
evidence literature available regarding massive transfusions, and thus, would be the foundation 
of our study. The scarcity of balanced transfusion data among non-trauma patients highlights the 
need for a specific investigation in this area. Our study is the first to examine balanced transfusion 
in a non-trauma cohort. We investigated 2 studies comprising of 580 non-trauma patients and 
reported on mortality outcomes. We found that a lower transfusion ratio is associated with  an 
increase in mortality among both groups, however, this was more pronounced among the non-
trauma patients (OR: 2.60, CI 1.51-4.49 non-trauma vs OR: 1.71, CI 1.47-1.98 for trauma). 
One of the concerns raised by opponents to  national implementation of balanced transfusion 
was the possibility for a rise in transfusion associated injuries especially in massively transfused 
patients. Murad and colleagues, in a meta-analysis of 12,421 patients who received MTP, found 
that the transfusion of plasma was associated with a higher rate of ALI (OR: 3.00, CI, 1.29-4.75) 
in surgical patients alone56 In the above mentioned randomized study and others the effect of 
transfusion ratio does not seem to influence the incidence of ARDS or ALI 14,35,45. This aligns with 
our results showing that ARDS and ALI were not associated with different transfusion ratios.  
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The limitation of this study is that almost all of our data are observational, and thus, survival bias 
cannot be excluded. The authors did not try to adjust for this bias as it applied to almost all of 
the observational data papers. Due to the limited data on MTP in non-trauma patients, our study 
has a small sample size. This, however, highlights an area of future research and provides a corner 
stone for future reviews.  
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Conclusion 
 
The use of high ratio, balanced transfusion will continue to be an important area of discussion 
and research. Our data suggests that there is a survival benefit at 24 hours and 30 days when this 
practice is followed, with the largest benefit within 24 hours. A ratio of 1:1.5 was associated with 
the highest survival benefit.  Furthermore, there is no evidence in our study of increased rates of 
ALI or ARDS. Ultimately a larger prospective randomized controlled trial with several thousand 
patients will be required to determine the best ratio of blood products in massive transfusion. 
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Table 1. Characteristics of included of included studies 
Study Year  Country Centers Study 
period 
Type of study 
Borgman (11) 2007 USA Brooke Medical Army Center/Iraq 2003-2005 Retrospective 
Borgman(1) 2011 Germany Multi center 2002-2007 Retrospective 
Brown(2) 2012 USA Multi center 2003-2010 Prospective 
Brown (21) 2011 USA Multi center 2005-2006 Retrospective 
De Biasi(3) 2011 USA University of Maryland School of 
Medicine, Baltimore 
2003-2008 Retrospective 
Dente(4) 2009 USA Multi center 2007-2008 Prospective 
Duchesene(23) 2008 USA Multi center 2002-2006 Retrospective 
Duchesene(22) 2009 USA Multi center 2001-2007 Retrospective 
Gunter(24) 2008 USA Multi center 2006-2007 Retrospective 
Hardin(25) 2014 USA Multi center 2003-2009 Retrospective 
Holcomb(14)  2015 USA Multi center 2012-2013 RCT 
Holcomb(26) 2008 USA Multi center 2005-2006 Retrospective 
Kashuk (27) 2008 USA Denver Health Medical Center 2001-2006 Retrospective 
Kim (28) 2014 Korea Ajou University School of Medicine 2010-2012 Retrospective 
Lustenberger(29) 2011 Switzerla
nd 
University Hospital of Zurich 1996-2006 Retrospective 
Maegele(30) 2008 Germany Cologne-Merheim Medical Center 2002-2006 Retrospective 
Magnotti(31) 2011 USA University of Tennessee Health 
Science Center,Memphis 
2006-2007 Retrospective 
Mazzeffi(32) 2016 USA University of Maryland School of 
Medicine 
2006-2014 Retrospective 
Mell(33) 2010 USA University of Wisconsin 1987-2007 Retrospective 
Mitra(34) 2010 Australia Alfred Hospital 2004-2008 Retrospective 
Nascimento(35
) 
2013 Canadian Multi center 2009-2011 RCT 
Peiniger(36) 2011 Germany University of Witten 2002-2008 Retrospective 
Rowell(37) 2011 USA Multi center 2005-2007 Retrospective 
Sharpe(38) 2012 USA Multi center 2006-2009 Retrospective 
Shaz(39) 2010 USA Emory University Rollins School of 
Public Health, Atlanta, Georgia 
2007-2009 Retrospective 
Snyder(12) 2008 USA University of Alabama-Birmingham 
(UAB) Hospital 
2005-2007 Retrospective 
Sperry(40) 2008 USA Multi center 2003-2007 Prospective 
Spinella(41)   2011 USA Multi center 2005-2006 Retrospective 
Spoerke(42) 2011 USA Multi center 2005-2007 Retrospective 
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Stanworth(43)  2015 UK Multi center Till 2011 Prospective 
Teixeira(44) 2009 USA Multi center 2000-2005 Retrospective 
Undurraga 
Peri(45) 
2015 USA Multi center 2012-2013 Retrospective 
Van(46) 2010 USA US army institute of surgical 
research 
2003-2008 Retrospective 
Wafaisade(47) 2011 Germany University of Witten/Herdecke, 
Cologne-Merheim Medical Center 
2005-2008 Retrospective 
Yang (48) 2015 China Medical College of Xi'an Jiaotong 
University 
2009-2010 Retrospective 
Zink(49) 2009 USA Oregon Health & Science University 2005-2006 Retrospective 
RCT: randomized control trial, USA: United States of America  
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Table 2. Patient details among FPR 1:2 included studies (n=18) 
Author Age 
Females 
(%) 
Military 
or Civilian 
ISS 
% Blunt 
injury 
Exclusion criteria 
Non-significant differences 
between groups 
Significant differences 
between groups 
Survival 
associated factors 
Overall 
mean FU 
(mean or 
median) 
NOS 
Borgman (1) 42 33 Civilian 42.5 92 Death within 60 min of ED 
admission 
Pressor-use, sepsis, single organ 
failure, MOF, vent-free days, ICU-
free days, time to death 
ICU LOS, in-hospital 
LOS, Mortality( 6hr, 
24hr, 30d and in-
hospital) 
Higher FPR D/C 8/9 
Brown(2)  40.5 27 Civilian NR 100 None specified  Male, Mechanisum of injury, HR, RR, 
Temp, units of PRBCs transfused 
age, GCS, PT, PTT, Plts, 
Hemoglobin, base 
deficit, systolic blood 
pressure, Units FFP 
transfused 
24-h crystalloid, 
24-h PRBC, Low 
hematocrit, No 
early 
laparotomy/thorac
otomy, Initial BD, 
No 24-h 
vassopressor use, 
ISS , APACHE II 
D/C 8/9 
Dente (4) 36 17 Civilian 29 59 Non-trauma patients  24hrs and in-hospital mortality after 
penetrating trauma  
24hrs and in-hospital 
mortality after blunt 
trauma 
FPR in blunt 
trauma 
D/C 8/9 
Duchesene; 
(22) 
30.25 11.25 Civilian 21.8 31.3 Patients < 18 years, who 
died in the ED, and 
nonsurvivable head 
injuries. 
Age, Gender,SBP, ISS, Penetrating 
trauma, Initial(HB,BD, INR), 
operation time 
ICU LOS, FPR Higher FPR D/C 9/9 
Holcomb (26) 39.8 24.7 Civilian 32.3 65.8 Death within 30 minutes 
of ED admission 
Gender, blunt trauma, admission 
HR, pH,Temp,Plt,ISS,AIS 
Age, SBP,admission BD, 
INR, GCS 
 Higher FPR 30 days 9/9 
Kashuk (27) 34.9 NR Civilian 35.9 59 Severe head injury (1ry 
cause of death), ED 
resuscitative 
thoracotomy, 
documented severe 
comorbidities; COPD, CAD, 
CRF, and liver cirrhosis  
NR RBC transfused at 6 
hours , INR at 6 hours 
1.5 , ED temperature  
34°C , and age 55 years.  
FPR associated 
with  coagulopathy 
reduction not 
survival 
D/C 7/9 
Kim (28) 47 17 Civilian 32 93 Death upon arrival to ED  
or within an hour  
Age, gender, Blunt injury,  Arrival-
Transfusion (min), RBC-FFP 
transfusion (min), Colloid (L),  Initial 
(hemoglobin, platelets, INR, pH, 
Units PRBC/24 hr, Units 
FPR at 24 hr, Units 
platelets/24 hr, 
Crystalloids/24 hr (L), 
Initial DBP (mmHg)   
Higher FPR D/C 9/9 
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lactic acid, base deficit),  Initial (SBP 
HR, RR, temp, GCS). 
Magnotti (31) 38 31  Civilian 31.5 63 None specified  Age, ISS, gender, blunt trauma, 
admission (SBP, HR,INR, Plt) 
Admission (BE, lactate) Blunt injury, 
admission BE 
D/C 8/9 
Mazzeffi (32) 60.3 38.9 Civilian NR NR None specified  Age, gender, weight, 
DM,Dyslipidemia, Hypertension, 
hemodialysis , baseline(creatinine, 
hematocrit, INR ) , Infectious 
endocarditis, CLD, CHF, LVEF,ICU  or 
hospital LOS  
Hight,Baseline platelet 
count, PVD, prior MI, 
Warfain use, emergency 
operation, CPB time 
Preoperative 
(platelet count, 
INR, 
thienopyridine) 
,CPB time. Patients 
with a highFPR had 
improved 30-day 
survival  
30 days/ 
D/C 
8/9 
Mell (33) 73 13.7 Civilian NR NR Symptomatic patients but 
intact aneurysms,  isolated 
iliac aneurysms, thoraco-
abdominal aneurysms, 
death prior to operating 
room arrival 
Age, weight, gender,hypertension, 
PVD, DM, Prior (MI, Stroke), 
operative time, blood loss, known 
AAA 
COPD Mortality higher in 
Age >80 ,Pre-
operative 
tachycardia,Urine 
output, FFP: RBC 
<1:2 
55 
months 
9/9 
Peiniger (36) 42 16.7 Civilian 41.7 90 Death within the first hour 
after admission  
Age, ISS, gender, blunt trauma,      
admission (SBP, HR, Plt, HB) 
GCS, BE, MOF, sepsis High FPR. RISC 
score  
30 days 9/9 
Rowell (37) 37.5 NR Civilian 32 64.4  transferred patients from 
other hospitals, 
incarcerated, pregnant, < 
16 years, burns, received 
CPR before ED, received  
ED thoracotomy,  death 
within 30 minutes  
ISS, GCS, BD, Age, AIS head, Temp SBP (in penetrating 
trauma), HR( in blunt 
trauma), INR 
Higher FPR 30 days 8/9 
Shaz (39) 35 18 Civilian 27.7 53.5 Nontrauma patients ISS, penetrating trauma, admission 
(HR, Temp, fibrinogen), GCS 
Mortality (24 hours and 
30 days) 
Higher FPR 30 days 7/9 
Snyder(12) 39.2 29 Civilian 36.5 100 None specified  NR high survival with higher 
FPR 
Higher FPR 30 days/ 
D/C 
7/9 
Spinella (41)   38 28.5 Military 35 100 Patients who died within 
the first hour of admission 
Age, ISS, gender, blunt trauma, 
admission (SBP, HR, GCS, Plt) 
BD Higher FPR 30 days 8/9 
Stanworth (43)  38 31 Civilian 28.5 77.4 Patients transferred from 
another hospital 
Gender, blunt trauma, SBP SBP on admission Higher FPR 1 year 7/9 
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Teixeira (44) 32 13 Civilian NR NR Head injury ( AIS score of≥ 
3 ) 
NR GCS 8, FPR,  Abdominal 
AIS≥3, Age≥55, SBP<90, 
Vascular injury  
Higher FPR D/C 8/9 
Van (46) 25.7 NR Military 14.6 41 None specified  CVA, MI, ARDS,PE, DVT  Renal failure  Higher FPR 30 days 8/9 
AAA; abdominal aortic aneurysm, AIS; abbreviated injury score, BD; base deficit, BE; base excess, CAD; coronary artery disease, CHF; congestive heart failure, CLD; chronic lung disease, CPB; cardio-pulmonary bypass, COPD; 
chronic obstructive pulmonary disease, CPR; cardiopulmonary resuscitation, CRF; chronic renal failure, CVA; cerebro-vascular accident, DVT; deep venous thrombosis, D/C; discharge, DM; diabetes mellitus, ED; Emergency 
department, FPR; fresh frozen plasma: packed red blood cells ratio ,GCS; Glasgow coma scale, HB; haemoglobin, HR; heart rate, ISS;  injury severity score,  LOS ; length of hospital stay, MBT; Massive blood transfusion, MI; 
myocardial infarction, MOF; multi-organ failure, NOS; Newcastle-Ottawa Scale, OEF; Operation Enduring Freedom, OIF;  Operation Iraqi Freedom, PE; pulmonary embolus, Plt; platelets,  PROPPR;  The Pragmatic, Randomized 
Optimal Platelet and Plasma Ratios, PVD; peripheral vascular disease, RISC ; Revised Injury Severity Classification score, rFVIIa; recombinant factor VIIa ,  SBP; systolic blood pressure, TIC; traumatic induced coagulopathy  
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Table 3. All outcomes of interest 
FPR Outcome 
Number 
of studies 
Cases OR 95% CI Heterogeneity Test for overall effect 
Outcome 
higher in 
All Studies 
(All Ratio; NO non-
trauma) 
24-hrs mortality 
22 12178 2.41 1.94-3.01 P<0.00001, I2=74% Z=7.87, P=<0.00001 low ratio 
All Ratio In-hospital/ 
30-day mortality 
27 13075 1.74 1.51-2.02 P=0.0001, I2=57% Z=7.44, P=<0.00001 low ratio 
All Ratio (Trauma) In-hospital/ 
30-day mortality 
25 12,495 1.71 1.47-1.98 P=0.0001, I2=58% Z=7.00, P=<0.00001 low ratio 
All Ratio (Non-
trauma) 
In-hospital/ 
30-day mortality 
2 580 2.60 1.51-4.49 P=0.32, I2=0% Z=3.44, P=0.0006 low ratio 
1:1 24-hrs mortality 
7 5265 2.05 1.55-2.71 P=0.03, I2=57% Z=5.00, P=<0.00001 low ratio 
1:1 In-hospital/ 
30-day mortality 
7 5266 1.36 1.09-1.69 P=0.09, I2=45% Z=2.74, P=<0.006 low ratio 
1:1.5 24-hrs mortality 4 1877 3.97 1.37-11.49 P=<0.0001, I2=88% Z=2.55, P=<0.01 low ratio 
1:1.5 In-hospital/ 
30-day mortality 
5 1813 2.31 1.14-5.25 P<0.001, I2=84% Z=2.40, P=0.02 low ratio 
1:2 24-hrs mortality 9 3540 2.85 2.14-3.81 P=0.01, I2=59% Z=7.10, P=<0.00001 low ratio 
1:2 In-hospital/ 
30-day mortality 
14 6193 1.77 1.50-2.10 P=0.08, I2=37% Z=6.68, P=<0.00001 low ratio 
All Studies ARDS 8 2678 0.68 0.40-1.16 P=0.0003, I2=74% Z=1.42, P=0.16 None 
All Studies ALI 2 780 1.23 0.81-1.86 P=0.73, I2=0% Z=0.96, P=0. 34 None 
FPR; Fresh frozen plasma: packed RBCs ratio, CI, confidence interval; OR, odds ratio 
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